[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BE747656A - IMPROVED PHARMACEUTICAL COMPOSITIONS CONSISTING OF A WATER-SOLUBLE SALT OF AN ACTIVE ACID COMPOUND AND A WATER-SOLUBLE EXCIPIENT ( - Google Patents

IMPROVED PHARMACEUTICAL COMPOSITIONS CONSISTING OF A WATER-SOLUBLE SALT OF AN ACTIVE ACID COMPOUND AND A WATER-SOLUBLE EXCIPIENT (

Info

Publication number
BE747656A
BE747656A BE747656DA BE747656A BE 747656 A BE747656 A BE 747656A BE 747656D A BE747656D A BE 747656DA BE 747656 A BE747656 A BE 747656A
Authority
BE
Belgium
Prior art keywords
water
soluble
pharmaceutical compositions
acid compound
active acid
Prior art date
Application number
Other languages
French (fr)
Inventor
J S Dwight
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BE747656A publication Critical patent/BE747656A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
BE747656D 1969-03-20 1970-03-19 IMPROVED PHARMACEUTICAL COMPOSITIONS CONSISTING OF A WATER-SOLUBLE SALT OF AN ACTIVE ACID COMPOUND AND A WATER-SOLUBLE EXCIPIENT ( BE747656A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB04670/69A GB1291281A (en) 1969-03-20 1969-03-20 Improvements in pharmaceutical compositions

Publications (1)

Publication Number Publication Date
BE747656A true BE747656A (en) 1970-09-21

Family

ID=10045462

Family Applications (1)

Application Number Title Priority Date Filing Date
BE747656D BE747656A (en) 1969-03-20 1970-03-19 IMPROVED PHARMACEUTICAL COMPOSITIONS CONSISTING OF A WATER-SOLUBLE SALT OF AN ACTIVE ACID COMPOUND AND A WATER-SOLUBLE EXCIPIENT (

Country Status (10)

Country Link
BE (1) BE747656A (en)
DE (1) DE2013039A1 (en)
DK (1) DK128674B (en)
ES (1) ES377725A1 (en)
FI (1) FI51653C (en)
FR (1) FR2035118B1 (en)
GB (1) GB1291281A (en)
IL (1) IL34089A (en)
NL (1) NL143419B (en)
SE (1) SE379284B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2083622B1 (en) * 1970-03-27 1975-08-22 Sankyo Co
US3969524A (en) * 1974-08-13 1976-07-13 Hoffmann-La Roche Inc. Stable amoxicillin dosage form
JPS5329936A (en) * 1976-08-31 1978-03-20 Takeda Chem Ind Ltd Antibiotic composition
DE2965732D1 (en) * 1978-12-08 1983-07-28 Beecham Group Plc Pharmaceutical composition comprising a water soluble salt of amoxycillin and polyvinylpyrrolidone, and a vial containing a unit dose of said composition
CA2061520C (en) * 1991-03-27 2003-04-22 Lawrence J. Daher Delivery system for enhanced onset and increased potency

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2438106A (en) * 1944-06-09 1948-03-23 Wyeth Corp Peroral penicillin compositions
US2864744A (en) * 1955-09-02 1958-12-16 American Home Prod Penicillin in solid dosage unit form
US3131123A (en) * 1959-03-13 1964-04-28 Lab Francais De Therapeutique Enteric tablets and manufacture thereof
GB1276839A (en) * 1968-08-02 1972-06-07 Sandoz Products Ltd Antibiotic compositions

Also Published As

Publication number Publication date
DE2013039A1 (en) 1970-09-24
IL34089A (en) 1974-05-16
FI51653C (en) 1977-03-10
ES377725A1 (en) 1972-10-16
FI51653B (en) 1976-11-30
DK128674B (en) 1974-06-17
NL7004004A (en) 1970-09-22
NL143419B (en) 1974-10-15
GB1291281A (en) 1972-10-04
FR2035118B1 (en) 1974-08-30
FR2035118A1 (en) 1970-12-18
IL34089A0 (en) 1970-05-21
SE379284B (en) 1975-10-06

Similar Documents

Publication Publication Date Title
NL191150C (en) N- (L-leucyl) doxorubicin and acid addition salts thereof, method of preparation and pharmaceutical preparation.
BE787771A (en) PREPARATION OF GLYOXYLIC ACID
BE752813A (en) PREPARATION OF OPTICALLY ACTIVE TRANS-CHRYSANTHEMIC ACID
BE819294A (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING N- (2-FURFURYL) -4-CHLORO-5-SULFAMOYL-ANTRANILIC ACID AND THEIR PREPARATION PROCESS
CA960668A (en) Preparation of 2-(6'-substituted-2'-naphthyl) propionic acid derivatives and salts thereof
BE747726A (en) PREPARATION OF ACID (+ OR -) - TRANS-CHRYSANTHEMIC
BE747656A (en) IMPROVED PHARMACEUTICAL COMPOSITIONS CONSISTING OF A WATER-SOLUBLE SALT OF AN ACTIVE ACID COMPOUND AND A WATER-SOLUBLE EXCIPIENT (
IL37467A0 (en) Derivatives of benzopyran-2-carboxylic acid,their preparation and pharmaceutical compositions containing them
BE769353A (en) BARBITURIC ACID DERIVATIVES AND CONTAINING COMPOSITIONS
SE420919B (en) PROCEDURE FOR THE PREPARATION OF N? 722-DANSYL-L-ARGIN INGREDIENTS AND PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS THEREOF
DK137681C (en) INSECTICIDES AND ACARICIDES ACTIVE O-ETHYL-S-N-PROPYL-O-VINYL-THIONOTHIOLPHOSPHORIC ACID ESTERS
BE747657A (en) PHARMACEUTICAL COMPOSITIONS CONSISTING OF A WATER-SOLUBLE SALT OF AN ACTIVE ACID COMPOUND AND A SUBSTITUTE AMINO CARBOXYLIC ACID (
BE808087A (en) PREPARATION OF GLYOXYLIC ACID
DK136250B (en) INSECTICIDES AND ACARICIDES ACTIVE O-ETHYL-S-N-PROPYL-O- (PYRIDAZ- (3) -ON- (6) -YL) -THIONOTHIOLPHOSPHORIC ACID RESIDENTS
BE792803A (en) OPTICALLY ACTIVE 8,12-DIISOPROSTANOIC ACID DERIVATIVES, THEIR PREPARATION AND COMPOSITIONS CONTAINING
BE844557A (en) NEW SALT OF ACID & -METHYL BENZOYL-5-THIOPHENE-2 ACETIC, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS
FR2283670A1 (en) 19,20-BIS-NOR-PROSTANOIC ACID DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IL34468A0 (en) Acid addition salts of indenopyridine derivatives,their preparation and pharmaceutical compositions containing them
BE796435A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING BENZOIC ACID DERIVATIVES
BE766354A (en) PREPARATION OF ORGANOPHOSPHORUS ACID ESTERS
IL37627A (en) 1,2,3,6-tetrahydro-4-pyridylmethyl esters of carboxylic acids and salts thereof,their preparation and pharmaceutical compositions containing them
GB1299037A (en) Dithiocarbamic acid esters
IL40623A (en) 14,15-dihydro-eburnamine-14-carboxylic acid derivatives and salts thereof,their preparation and pharmaceutical compositions containing them
BE745054A (en) PREPARATION OF PHOSPHONIC ACID DERIVATIVES
GB1287433A (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: PFIZER CORP.

Effective date: 19850319